Tolerance and efficacy of branded generic pemetrexed maintenance in Indian patients of metastatic non-squamous non-small-cell lung cancer.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Abstract:
      The article offers information on the role of pemetrexed maintenance (PM) in advanced non‑squamous non‑small cell lung cancer (NS‑NSCLC) in terms of Progression-free survival (PFS), overall survival (OS), and adverse effects (AEs). It mentions the study tested the concept of continuation branded generic PM in Indian population for efficacy and AEs; and also mentions platinum‑based first‑line chemotherapy has improved OS in patient with advanced NSCLC.